ZALTRAP is an option for people who have had their cancer worsen or have become resistant to the initial therapy used to treat their metastatic colorectal cancer (mCRC). Those who receive ZALTRAP have been previously treated with a chemotherapy called oxaliplatin (ox-alley-plaht-in).

Aflibercept (Zaltrap), in combination with fluorouracil, leucovorin, and irinotecan (known as FOLFIRI), is indicated for the treatment of people with metastatic colorectal cancer that is resistant to, or has progressed following, an oxaliplatin-containing regimen.

May 31, 2024 · What is Zaltrap? Zaltrap is made from a human antibody fragment. It works by keeping new blood vessels from forming in a fast-growing tumor. Zaltrap is used in combination with other medications to treat colorectal cancer that has spread to …

ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed …

ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen.

3 days ago · The US Food and Drug Administration (FDA) has announced it has approved colon cancer drug, Zaltrap, for use in combination with a folinic acid, fluorouracil and iriontecan (FOLFIRI) chemotherapy...

Jan 2, 2024 · ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen. (1)

COMMON BRAND NAME(S): Zaltrap. USES: Ziv-aflibercept is used to treat cancer of the colon and rectum. HOW TO USE: This medication is given by injection into a vein by a health care...

Jan 7, 2025 · Zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is used for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.

Jan 8, 2024 · ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan- (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.